BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ALK-Abello A/S Announces Top-Line Results From Its Partner Merck & Co.'s North American Phase III Trial Of House Dust Mite SLIT-Tablet

  June 4, 2015

   · 

  3 min read
• FDA

  St. Jude Medical Grabs CE Mark Approval of Industry’s First Neuromodulation Trial System to Employ Apple and Bluetooth Wireless Technology

  June 4, 2015

   · 

  5 min read
• Drug Development

  Regulus Initiates Phase I Clinical Study Of RG-012, A microRNA Therapeutic In Development For The Treatment Of Alport Syndrome

  June 4, 2015

   · 

  8 min read
• Business

  WuXi AppTec, Inc. Partners With Fudan University And The Collaborative Innovation Center Of Genetics And Development

  June 4, 2015

   · 

  4 min read
• Biotech Beach

  University of Southern California Receives $25 Million Gift To Name USC Tina And Rick Caruso Department Of Otolaryngology - Head And Neck Surgery And USC Caruso Family Center For Childhood Communication

  June 4, 2015

   · 

  8 min read
• Biotech Beach

  OncoSec Medical Inc. To Present At The BIO International Convention

  June 4, 2015

   · 

  3 min read
• Actavis To Present At The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference

  June 4, 2015

   · 

  2 min read
• Biotech Bay

  IMPAX Labs To Present At The Goldman, Sachs & Co. 36th Annual Global Healthcare Conference

  June 4, 2015

   · 

  1 min read
• Pharm Country

  Egalet Release: In a Clinical Alcohol Interaction Study Egalet-002, An Abuse-Deterrent, Extended-Release Oxycodone Product Candidate, Did Not Induce Alcohol Dose Dumping -- An Important Attribute Given Alcohol Use Seen With Chronic Pain Patients

  June 4, 2015

   · 

  5 min read
• ITM Group Release: Isotope Technologies Garching Announces Successful Validation of EndolucinBeta (n.c.a. Lutetium-177) Marketing Authorization Application By The European Medicines Agency

  June 4, 2015

   · 

  2 min read